Purpose: The pharmacology, pharmacokinetics ... Summary: Duloxetine is a balanced selective serotonin and norepinephrine-reuptake inhibitor available in the United States for the treatment ...

Microdosing might not work the way we think—but that doesn’t mean it doesn’t work. Here’s what science and the placebo effect ...

The differences in risk of sudden cardiac death varied by age and how long people took antidepressants, with people taking ...

Bright Minds Biosciences has a decent balance sheet, with roughly $40.3 million in cash. Click here to find out why I rate ...

The study, published today in the journal Psychedelics, demonstrates that mice treated with a single dose of 25CN-NBOH, a ...

Single-Dose Psychedelics and Cognitive Adaptation. The figure depicts a mouse with a lightbulb, symbolizing the remarkab ...

The goal of the present study was to describe the molecular pharmacology of OPC-14597 ... as well as at novel serotonin receptor subtypes (5-HT 6 and 5-HT 7). Antagonism of dopamine-mediated ...

A new scientific review published in Neuropharmacology explores how the environment interacts with brain biology in shaping personality disorders. By examining molecular, neurochemical, and metabolic ...

Doug Drysdale, CEO of Cybin opens up to Invezz about the benefits of psychedelics based drugs, why psychedelic stocks are struggling and how Big Pharma may soon get involved in the sector.